Screener
Alamar Biosciences ALMR Service Other — Cost Of Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Alamar Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213424
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total revenue | 26,035 | 13,091 |
| Cost of revenue: | ||
| Cost of product revenue | 9,810 | 5,371 |
| Cost of service and other revenue | 1,768 | 1,331 |
| Total cost of revenue | 11,578 | 6,702 |
| Gross profit | 14,457 | 6,389 |
| Operating expenses: | ||
| Research and development | 13,017 | 8,302 |
Item 1. Financial Statements
FAQ
- What is Alamar Biosciences's service other — cost of revenue?
- Alamar Biosciences (ALMR) reported service other — cost of revenue of $1.77M in Q1 2026.
- What does service other — cost of revenue mean?
- This metric encompasses the direct costs incurred to deliver secondary services, including labor, materials, and overhead associated with contract research or technical support activities. It reflects the operational efficiency of the service business unit in executing client projects. Monitoring this cost helps assess the scalability and margin profile of the company's service-based revenue streams.
Ask your AI about Alamar Biosciences's service other — cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude